Home > Financial Ratios > SHUKRA PHARMACEUTICALS

SHUKRA PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for SHUKRA PHARMACEUTICALS
Please provide your vote to see the results

SHUKRA PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -23.77238.70121.1264.8116.13

What is the latest Core EBITDA Growth ratio of SHUKRA PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of SHUKRA PHARMACEUTICALS is -23.77 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025-23.77
Mar2024238.70
Mar2023121.12
Mar202264.81
Mar202116.13

How is Core EBITDA Growth of SHUKRA PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 -23.77
Negative
Mar2024 238.7
97.08
Mar2023 121.12
86.88
Mar2022 64.81
301.80
Mar2021 16.13 -

Other Financial Ratios of SHUKRA PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of SHUKRA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SHUKRA PHARMACEUTICALS ₹2,071.3 Cr -12.7% 1.9% 186.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,073.0 Cr -0% -3.2% -5% Stock Analytics
DIVIS LABORATORIES ₹175,657.0 Cr 4% 5.2% 11.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,121.0 Cr 2.4% 4.5% 18.3% Stock Analytics
CIPLA ₹118,431.0 Cr -3.5% -1.5% -2.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,944.0 Cr -3.2% -3.3% -10.6% Stock Analytics


SHUKRA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SHUKRA PHARMACEUTICALS

-12.7%

1.9%

186.3%

SENSEX

-2.6%

-1.3%

7.2%


You may also like the below Video Courses